5,100 Shares in CME Group Inc. $CME Purchased by Trivium Point Advisory LLC

Trivium Point Advisory LLC purchased a new position in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, HoldingsChannel reports. The firm purchased 5,100 shares of the financial services provider’s stock, valued at approximately $1,126,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its holdings in CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its position in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after buying an additional 37 shares during the last quarter. Endowment Wealth Management Inc. grew its position in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock worth $244,000 after buying an additional 38 shares during the last quarter. Finally, NBT Bank N A NY increased its holdings in shares of CME Group by 2.3% in the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after buying an additional 38 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently commented on CME shares. Morgan Stanley increased their price objective on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. lifted their target price on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft cut their target price on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and upped their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, TD Cowen decreased their price target on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $291.81.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $269.80 on Monday. The firm’s 50 day moving average price is $250.20 and its two-hundred day moving average price is $280.19. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The stock has a market cap of $97.01 billion, a price-to-earnings ratio of 22.88, a PEG ratio of 3.14 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.96 earnings per share. Equities analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.